Blood proteins and nail blood vessels in alopecia areata
Part of Skin clinical trials.
This study looks at whether certain proteins in your blood (VEGF-A and VCAM-1) are linked to changes in the tiny blood vessels at the base of your fingernails in people with alopecia areata. It may help doctors understand more about the condition and how it affects the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have been diagnosed with alopecia areata by a dermatologist.
- You do not have diabetes, autoimmune diseases, or other chronic inflammatory or vascular conditions.
- You are not pregnant or breastfeeding.
- You do not smoke or drink heavily.
- You have not had a manicure in the last 3 weeks and have no other nail disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain blood markers (GPX4 and MDA) related to a process called ferroptosis in people with Alopecia Areata. The goal is to better understand this condition and possibly find new treatment targets.
This study uses a special UV light to look at your scalp in a new way. It may help doctors better understand and monitor alopecia areata (a condition that causes patchy hair loss). Participation involves only imaging, no drugs or invasive procedures.
This trial tests if microneedling with either lactic acid, vitamin D3, or a steroid cream helps regrow hair in people with patchy alopecia areata (small bald spots).
This study tests an experimental oral tablet for severe alopecia areata, a condition that causes patches of hair to fall out. The goal is to see if it can help regrow hair safely. You may be able to join if you have this type of hair loss and meet the health requirements.
This study looks at inflammation in people with vitiligo, psoriasis, atopic dermatitis, or alopecia areata. It aims to understand how these conditions compare, which may lead to better treatments.
This study tests whether transplanting healthy gut bacteria (called a fecal microbiota transplant) can help treat alopecia areata, a condition that causes patchy hair loss. By restoring a balanced gut microbiome, the treatment may reduce inflammation and potentially promote hair regrowth.
Hear when a new Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.